Bluechiip Limited

ASX:BCT ISIN:AU000000BCT7

Bluechiip Ltd ASX BCTBluechiip Ltd (ASX:BCT) understands that every sample - stem cells, blood, eggs, sperm and other biospecimens - is critical, so our objective is to manage each one with optimal quality in the most efficient way. Bluechiip's advanced management solution is the only one that provides sample temperature with ID in cryogenic environments to. Most importantly, this delivers confidence in every sample.

Bluechiip's unique patented technology is a MEMS-based wireless tracking solution that contains no electronics. It represents a generational change from current tracking methods such as labels (hand-written and pre-printed), barcodes (linear and 2D), and Radio Frequency Identification. Bluechiip tags are either embedded or manufactured into storage products such as vials or bags. Each product can be easily identified, and critical information such as sample temperature, is detected by readers and stored in the Bluechiip software. In addition to functioning in extreme temperatures, the Bluechiip(R) Advanced Sample management solution can survive autoclaving, gamma irradiation sterilization, humidification, centrifuging, cryogenic storage and frosting.

Bluechiip's technology has applications in healthcare, including in cryogenic storage facilities (biobanks and biorepositories), pathology, clinical trials and forensics. Other key markets include cold-chain logistics/supply chain, security/defence, industrial/manufacturing and aerospace/aviation.

Bluechiip: Delivering confidence in every sample.

 

 
    
            

View in Other Languages

News

Bluechiip Ltd (ASX:BCT) FY18 Highlights

🕔8/28/2018 9:57:12 AM 3772

Bluechiip Ltd (ASX:BCT) provides the Company's 2017-18 Highlights.

Read Full Article

Bluechiip Ltd (ASX:BCT) June 2018 Quarterly Report

🕔7/31/2018 10:04:32 AM 3611

Bluechiip Limited (ASX:BCT) today released its quarterly cash flow report for the period ended 30 June 2018.

Read Full Article

Bluechiip Ltd (ASX:BCT) Open Briefing Interview with MD Andrew McLellan

🕔6/25/2018 12:04:55 PM 3808

Bluechiip Ltd (ASX:BCT) provides the record of Open Briefing interview with Managing Director, Andrew McLellan on Bluechiip deliveries, recent trade show and market update.

Read Full Article

VIDEO: Bluechiip Ltd (ASX:BCT) CommSec Executive Series Interview with Andrew McLellan

🕔4/24/2018 2:28:41 PM 15351

Andrew McLellan, Bluechiip Limited (ASX:BCT) Managing Director, was recently interviewed as part of the CommSec Executive Series. In the interview Andrew McLellan explains the Company's technology, progress with Original Equipment Manufacturers and other recent initiatives.

Read Full Article

Bluechiip Ltd (ASX:BCT) Change of Share Registry

🕔7/17/2017 8:20:06 AM 3754

Bluechiip Limited (ASX:BCT) advises that as of Monday, 17 July 2017, the Company has changed its provider for shareholder registry services from BoardRoom Pty Limited to Automic Registry Services.

Read Full Article

Bluechiip Ltd (ASX:BCT) Bluechiip raises $3.425M from Rights Issue and Placement

🕔7/5/2017 5:53:58 PM 4501

Bluechiip Ltd (ASX:BCT), a leader in the development of sample tracking technology for harsh environments, today announced that its pro rata 1-for-3 nonrenounceable rights issue at an issue price of $0.028 per ordinary share and its associated Top-Up Facility to raise up to $2.53 million successfully closed on 30 June 2017.

Read Full Article

Bluechiip Ltd (ASX:BCT) First Products Shipped to Labcon North America

🕔6/21/2017 8:54:53 AM 3789

Bluechiip Limited (ASX:BCT), a leader in the development of sample tracking technology for harsh environments, is pleased to provide this company update.

Read Full Article

Bluechiip Ltd (ASX:BCT) Rights Issue - Dispatch of Offer Document

🕔6/14/2017 8:27:58 AM 3451

Bluechiip Ltd (ASX:BCT) confirms that the Offer Document, together with personalised entitlement and acceptance form, for the non-renounceable rights issue announced by the Company on 1 June 2017, was sent to all eligible shareholders.

Read Full Article

Bluechiip Ltd (ASX:BCT) Rights Issue to Raise up to $2.53 Million

🕔6/6/2017 1:05:45 PM 3901

Bluechiip Limited (ASX:BCT) announced to the ASX a non-renounceable rights issue at an issue price of $0.028 per new share.

Read Full Article

Bluechiip Ltd (ASX:BCT) Rights Issue Offer Document

🕔6/5/2017 9:52:01 AM 3391

This Offer Booklet relates to an Offer of New Shares to Eligible Shareholders of Bluechiip Limited (ASX:BCT) by way of a nonrenounceable rights issue. This Offer Booklet is dated 5 June 2017 and was lodged with ASX on that date. The ASX does not take any responsibility for the contents of this Offer Booklet.

Read Full Article
###

113,343 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 203) (Last 30 Days: 799) (Since Published: 73201) 

Company Data

    Headquarters
  • 1 Dalmore Drive
    Caribbean Business Park
    Scoresby VIC 3179 AUSTRALIA
  • Telephone
  • +61-3-9763-9763 
  • Fax
  • +61-3-9763-9764 
  • Principal Sector
  • Infrastructure & Technology 
  • Principal Industry
  • Healthcare 
  • Homepage
  • www.bluechiip.com

Company Reports

More News Results

  • 2024/07/10: BCT expansion order from Global Pharma client and Update*
  • 2024/07/05: Change of Company Secretary*
  • 2024/06/19: Change in substantial holding*
  • 2024/06/17: Cleansing Notice*
  • 2024/06/17: Application for quotation of securities - BCT*
  • 2024/06/12: Company Update*
  • 2024/06/12: Proposed issue of securities - BCT*
  • 2024/06/12: Proposed issue of securities - BCT*
  • 2024/06/12: Bluechiip completes placement*
  • 2024/06/07: Trading halt*
*refer to company website

Presentations

Download Presentation

Research Report

Download Presentation

Quarterly Report

Download Presentation

Social Media